IGF-LR3

IGF-LR3 is a recombinant analog of insulin-like growth factor 1, and the most important thing to understand about it is that it is a protein rather than a peptide. At 83 residues with three intramolecular disulfide bonds and a folded tertiary structure, it is produced by expression in a bacterial host rather than by solid-phase synthesis, and essentially everything about its handling and verification follows from that.

Two modifications distinguish it from native IGF-1. An arginine substitutes for glutamate at position 3, which sharply reduces affinity for the insulin-like growth factor binding proteins that otherwise sequester the molecule. A 13-residue N-terminal extension accounts for the remainder of the length difference. Its target is the IGF-1 receptor, a receptor tyrosine kinase and therefore mechanistically unrelated to the G-protein-coupled receptors engaged by every other compound in this category.

The binding-protein interaction is the point of the design and the focus of much of the reported work. Native IGF-1 in circulation is largely bound to its binding proteins, so studies comparing free fraction and receptor availability between the native molecule and the Arg3 analog are the characteristic experiments in this literature.

Receptor-level work uses phosphorylation assays measuring receptor autophosphorylation and downstream Akt and MAP kinase signalling in cultured cells, which are the standard readouts for a receptor tyrosine kinase rather than the cAMP or calcium assays used across the rest of this category.

Release testing for a recombinant protein differs substantially from that for a synthetic peptide, and a Certificate of Analysis that looks like a peptide COA is a warning sign for this material. Correct disulfide pairing and tertiary folding are the primary attributes: a misfolded molecule can be entirely correct by mass and by amino acid composition while being inactive, so mass spectrometry alone is insufficient.

Bacterial expression introduces impurity classes that solid-phase synthesis does not: residual host cell protein, host nucleic acid, and bacterial endotoxin, the last of which is biologically active in cell culture at very low concentrations and is a frequent confounder in experiments that appear to show an effect. SDS-PAGE and size-exclusion chromatography are the appropriate methods for detecting aggregate and truncated species, neither of which a reversed-phase purity figure reports reliably for a folded protein.